MGMT and central nervous system cancer: Promoter methylation of O6-methylguanine-DNA methyltransferase (MGMT)—the major enzyme involved in repair of DNA damage induced by TMZ [7–10]—serves as a useful predictor for glioma responsiveness to TMZ [11–13].